ANC-501 in the Treatment of Adults With Major Depressive Disorder
Public ClinicalTrials.gov record NCT05439603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of ANC-501 in the Treatment of Adults With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 Study of ANC-501 in the treatment of adults with Major Depressive Disorder
Study identification
- NCT ID
- NCT05439603
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2022 (Actual)
- Primary completion
- Aug 14, 2023 (Actual)
- Completion
- Oct 18, 2023 (Actual)
- Last update posted
- Dec 31, 2024
2022 – 2023
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ATP Clinical Research | Orange | California | 92868 | — |
| Florida Behavioral Medicine | Largo | Florida | 33770 | — |
| Innovative Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| Combined Research Orlando | Orlando | Florida | 32807 | — |
| Clinilabs Drug Development Corporation | Eatontown | New Jersey | 07724 | — |
| Clinilabs Drug development Corporation | New York | New York | 10016 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10314 | — |
| Conrad Clinical Research | Edmond | Oklahoma | 73013 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05439603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 31, 2024 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05439603 live on ClinicalTrials.gov.